XXII 22nd Century Group Inc.

22nd Century to Participate in September and October 2021 Investor Conferences

22nd Century to Participate in September and October 2021 Investor Conferences

BUFFALO, N.Y., Sept. 27, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: ), a leading agricultural biotechnology and intellectual property company focused on improving health and wellness through plant science, today announced that the Company will participate in the following virtual investor conferences during the months of September and October 2021:

  • On Wednesday, September 29, 2021, at 8:50 a.m. ET, the Company will host a fireside chat at the BTIG Cannabis Conference. BTIG-hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative.



  • On Tuesday, October 12, 2021, at 9:30 a.m. ET, the Company will conduct a virtual presentation at the 2021 LD Micro Main Event Conference. A webcast will be available via a link on the Company’s Investor Relations website under the Events subtab at:



  • On Thursday, October 21, 2021, at 10:00 a.m. ET, the Company will be present at the 2021 Dawson James Sixth Small Cap Growth Stock Conference. A webcast of the group presentation will be available via the Company’s Investor Relations website under the Events subtab at:

During his presentations, James A. Mish, chief executive officer of 22nd Century Group, will highlight the Company’s business development, commercialization, and value creation efforts across its three high-value plant-based franchises. He will discuss plans for commercializing VLN® reduced nicotine content cigarettes in the U.S. and international markets, expectations for monetizing proprietary hemp/cannabis plant lines and IP by the end of this year, and the Company’s development plans following its recently announced entry into the specialty hops market.

Institutional investors and those invited to attend these virtual conference events may request one-on-one meetings with representatives of the Company, where offered, through the respective conference hosts or by contacting 22nd Century Group’s investor relations team via .

22nd Century Group, Inc. (Nasdaq: ) is a leading agricultural biotechnology and intellectual property company focused on improving health and wellness through plant science. 22nd Century uses modern plant breeding technologies, gene-editing, and molecular breeding to deliver value to its customers in the life science and consumer products industries by creating new, proprietary tobacco, hemp/cannabis and hop plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits. 22nd Century was founded to build intellectual property related to nicotine biosynthesis in the tobacco plant and to commercialize its proprietary reduced nicotine content (RNC) tobacco plants, which have become the cornerstone of to address the enormous amount of death and disease caused by addiction to smoking. The Company has also begun to leverage its plant science expertise and existing partnerships to create and commercialize new, proprietary hemp/cannabis and hop plants to optimize their genetics and create valuable new intellectual property.

Learn more at , on Twitter , and on .

Cautionary Note Regarding Forward-Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 11, 2021. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

Investor Relations & Media Contact:

Mei Kuo

Director, Communications & Investor Relations

22nd Century Group, Inc.

(716) 300-1221



EN
27/09/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 22nd Century Group Inc.

 PRESS RELEASE

Emerging Growth Research Releases Q2 2025 Update Report on 22nd Centur...

New York, New York--(Newsfile Corp. - August 22, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q2 2025 results. The report reflects ongoing operational restructuring under new management and revised outlook for EBITDA breakeven pushed to Q2 2026 due to slower-than-expected CMO stabilization and VLN® rollout timing.22nd Century Group Q2 2025 Financial Highlights:Q2 2025 revenue of $4.1 million, down 49% year-over-year from $7.9 million in Q2 2024Q2 2025 revenue declined 31% sequentially from...

 PRESS RELEASE

Emerging Growth Research Releases Q1 2025 Update Report on 22nd Centur...

New York, New York--(Newsfile Corp. - May 21, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q1 2025 results. The report reflects the continued operational progress made under new management and the outlook for meaningful financial improvement in 2025.22nd Century Group Q1 2025 Financial Highlights:Q1 2025 revenue of $6.0 million, up 48% from Q4 2024Q1 2025 gross profit improved to $(0.6) million from $(1.3) million in Q4 2024Operating loss narrowed significantly to $(2.6) million from $(4.4...

 PRESS RELEASE

Emerging Growth Research Releases Quarterly Update Report on 22nd Cent...

Sheridan, Wyoming--(Newsfile Corp. - April 10, 2025) - Emerging Growth Research is pleased to release its latest quarterly update on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q4 2024 results. The report reflects the continued operational progress made under new management and the outlook for meaningful financial improvement in 2025.To read the full report, please visit: Q4 2024 Financial Highlights:Revenue was $4.0 million, down 45% YoY, reflecting expected attrition due to CMO contract price hikes. Gross profit improved YoY to $(1.3) million from $(7.8) million. Opera...

 PRESS RELEASE

Emerging Growth Research Releases New Initiation Report on the 22nd Ce...

Sheridan, Wyoming--(Newsfile Corp. - February 19, 2025) - Emerging Growth Research is pleased to announce the release of its new initiation report on the 22nd Century Group, Inc. (NASDAQ: XXII). The Company has made significant strides in its operational and financial restructuring under new management, with only the warrant overhang remaining to be addressed. To read this report, please visit XXII's landing page on the Emerging Growth website, located here: .XXII's new management has successfully reduced operating cash losses in the first nine months of 2024 and further decreased the Company'...

 PRESS RELEASE

22nd Century Secures $3.2 Million to Date in Warrant Exchange Transact...

22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction Newly Appointed CEO Leading Restructuring to Focus on Tobacco Industry Operations, Reduce Costs BUFFALO, N.Y., Dec. 04, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the exercise of warrants by certain holders pursuant to its previously announced warrant inducement offering. During the inducement period, certain holders of the Company’s existing warrants acqui...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch